Fortis Malar Stock Price Today (NSE: 523696)

Fortis Malar

523696Hospital
41.400.40 (0.96%)
Market Closed

Fundamental Score

...

Fortis Malar Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Fortis Malar share price today is 41.40, down 0.96% on NSE/BSE as of 22 September 2026. Fortis Malar (523696) is a Small-cap company in the Hospital sector with a market capitalisation of 77.59 (Cr). The 52-week high for 523696 share price is 76.00 and the 52-week low is 40.75. At a P/E ratio of 341.36x, 523696 is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 13.01% and a debt-to-equity ratio of N/A.

Fortis Malar Share Price Chart — NSE/BSE Historical Performance

No data
High
51.49
Low
41.40
Volume
5.5K
Change
-5.77%

Fortis Malar share price chart: -5.77% return over the past month. 52-week high ₹76.00, 52-week low ₹40.75.

Fortis Malar — Last 10 Trading Days

DateOpenHighLowCloseVolume
48.1148.1146.5047.168.89K (Cr)
47.0148.9046.7047.354.50K (Cr)
47.0047.7647.0047.482.23K (Cr)
47.1147.9046.5047.058.09K (Cr)
47.5048.2047.2047.335.12K (Cr)
47.9548.9847.5047.775.04K (Cr)
49.0049.0547.4048.0117.37K (Cr)
49.3049.4048.5049.054.13K (Cr)
48.6249.3648.5148.825.74K (Cr)
49.4049.4548.0048.573.79K (Cr)

Fortis Malar — Last 12 Months Price History

MonthOpenHighLowCloseChange
49.6251.4546.5047.16-4.96%
51.2053.2048.1050.74-0.90%
54.0058.4050.0052.10-3.52%
56.0058.9052.0053.98-3.61%
42.0060.0042.0056.00+33.33%
46.6554.3540.7541.69-10.63%
57.9858.3052.5054.06-6.76%
59.4063.0052.2455.74-6.16%
63.0565.0056.2658.54-7.15%
66.9967.7462.2063.73-4.87%
64.0076.0064.0066.65+4.14%
65.0066.5064.0064.87-0.20%

Returns & Performance

Poor

Return on Equity (ROE)

13.01%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.64%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

2.94%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Fortis Malar Valuation Check

Poor

Price to Earnings (P/E)

341.36x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

48.79x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

62.71%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.07%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-95.67%

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

17.93%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

17.93%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Debt to Equity Ratio

N/A

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

1.85 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Fortis Malar Fundamental Analysis & Valuation Benchmarking

Educational evaluation of 523696 across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Excellent EPS Growth (17.93% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (17.93% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Healthy Liquidity Position (Current Ratio: 11.33)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Balanced Promoter Holding (62.71%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Margin Pressure Concerns (2.94%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 341.36x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-95.67%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Institutional Interest (FII+DII: 0.07%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Fortis Malar vs Hospital Peers

Peer Comparison - Hospital

Compare Fortis Malar with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
37.6/100
41
₹77.59
341.4
Average
13.01%
Average
14.64%
Average
17.93%
Excellent
0.00%
62.1/100
8967
₹128945.46
61.7
Average
21.95%
Excellent
19.28%
Good
0.6
Good
66.81%
Excellent
19.03%
Excellent
0.22%
56.9/100
1038
₹100973.65
69.2
Average
14.33%
Average
13.43%
Average
0.3
Excellent
60.01%
Excellent
27.30%
Excellent
0.18%
56.8/100
915
₹69078.84
65.9
Average
11.08%
Average
12.83%
Average
0.3
Excellent
64.38%
Excellent
17.76%
Excellent
0.10%
37.2/100
780
₹40432.27
126.3
Average
9.70%
Poor
11.35%
Average
0.2
Excellent
21.31%
Excellent
-11.61%
Poor
0.61%
59.9/100
1480
₹39788.71
71.5
Average
15.15%
Good
16.85%
Good
0.3
Excellent
80.71%
Excellent
24.97%
Excellent
0.04%
68.3/100
1891
₹38636.49
47.1
Average
19.74%
Good
14.53%
Average
1.1
Average
155.30%
Excellent
25.05%
Excellent
0.22%
13.9/100
762
₹31985.10
149.3
Average
11.01%
Average
9.35%
Poor
1.4
Average
3.71%
Average
24.04%
Excellent
0.00%
48.5/100
514
₹16284.29
109.5
Average
6.84%
Poor
10.16%
Average
0.1
Excellent
34.42%
Excellent
34.58%
Excellent
0.00%
65.5/100
1451
₹14738.24
51.6
Average
17.86%
Good
18.10%
Good
0.0
Excellent
44.04%
Excellent
21.24%
Excellent
0.23%
42.7/100
713
₹10638.37
459.7
Average
1.22%
Poor
7.43%
Poor
0.7
Good
17.65%
Excellent
20.22%
Excellent
0.00%

Fortis Malar Quarterly Performance

Latest quarterly metrics for 523696 — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-95.67%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

17.93%

Compounded annual net profit growth over 5 years

Fortis Malar Technical Indicators

SMA 50, SMA 200, RSI and volume signals for 523696 — calculated from daily price history

31RSI 14
Neutral — RSI 31

Momentum is balanced — neither overbought nor oversold.

SMA 50
50
▼ Price below SMA 50 — Short-term bearish
SMA 200
55
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
6K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Fortis Malar Financial Statements

Annual income statement, balance sheet and cash flow for Fortis Malar (523696) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Fortis Malar

Loading latest quarterly results...

About 523696 (Fortis Malar)

Fortis Malar (523696) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market cap...italisation of ₹77.59 (Cr). Fortis Malar has delivered a Return on Equity (ROE) of 13.01% and a ROCE of 14.64%. Investors tracking 523696 share price can monitor key metrics including P/E ratio, promoter holding of 62.71%, and quarterly earnings growth.

Company Details

Symbol:523696
Industry:Hospital
Sector:Hospital
Website:N/A

523696 Share Price: Frequently Asked Questions

What is the current share price of Fortis Malar?

Fortis Malar (523696) trades at ₹41.40 on BSE. Market cap ₹77.59 (Cr). Educational data only.

What is the P/E ratio of Fortis Malar?

Fortis Malar has a P/E of 341.36x vs industry average 48.79x.

What is the Bull Run score for Fortis Malar?

Fortis Malar has a Bull Run score of 37.6/100 based on 25+ financial parameters.

Does Fortis Malar pay dividends?

Fortis Malar has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Fortis Malar?

Fortis Malar has ROE of 13.01%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Fortis Malar?

Fortis Malar has debt-to-equity of N/A.

Is Fortis Malar a good investment?

Bull Run gives Fortis Malar a score of 37.6/100. This is not investment advice — consult a SEBI-registered advisor.